Chronic Kidney Diseases
692
140
172
310
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
55 trials with published results (8%)
Research Maturity
310 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.0%
28 terminated out of 692 trials
91.7%
+5.2% vs benchmark
11%
73 trials in Phase 3/4
18%
55 of 310 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 310 completed trials
Clinical Trials (692)
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
Chronic Kidney Disease-Education (CKD-EDU)
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
Chronic Kidney Disease Registry Platform Study
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Immunogenicity of HPV Vaccine in Transplant Recipients.
NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus
A Delphi Survey for Key Stakeholders to Identify Priority Self-management Outcomes for Chronic Kidney Disease
Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial
Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male Subjects
Lokelma for RAAS Maximisation in CKD & Heart Failure.
Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD
Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease
Effects of Prebiotic Supplementation and Exercise on Inflammatory Markers, Vascular Function and Cognition in CKD
Concomitant Renal and Urinary Bladder Allograft Transplantation
Simultaneous Starting of the 4 Guideline Directed CKD Therapies (RAPID-CKD)